Chinese Biotech Firm Fapon Showcases SI-Engineered Enzymes at Molecular Pathology Meeting in Seattle
The Association for Molecular Pathology’s 2026 annual meeting runs November 10-14 at the Seattle Convention Center, where Chinese biotechnology company Fapon is exhibiting at booth 1905, presenting its SI-engineered enzymes, reverse transcription product portfolio and end-to-end RNA and DNA library preparation workflows.
On November 11, from 10:00 to 10:50 a.m., Fapon will also hold a workshop in Tahoma Room 5 on the convention center’s third floor, where Dr. Ning Wu will present the technical path from enzyme engineering to practical applications. The molecular pathology meeting is a major global academic event in molecular diagnostics and pathology, drawing testing institutions, hospital laboratories and biotechnology companies from many countries this year.
Fapon said it hopes to use the meeting to build partnerships with clinical laboratories and research institutions in the western United States and to expand the use of its enzyme and library preparation products in the North American market. Seattle, a biotechnology hub in the Pacific Northwest and home to institutions such as the University of Washington and the Fred Hutchinson Cancer Center, has in recent years become an important foothold for Chinese biotech companies entering the North American market.
Source: PR Newswire
Published by GSM · USA (original Chinese edition)
Photo: 西雅图会议中心资料图。（A4LE）
